JP2023513955A - ウイルス配列を検出するための組成物、キット、及び方法 - Google Patents

ウイルス配列を検出するための組成物、キット、及び方法 Download PDF

Info

Publication number
JP2023513955A
JP2023513955A JP2022549760A JP2022549760A JP2023513955A JP 2023513955 A JP2023513955 A JP 2023513955A JP 2022549760 A JP2022549760 A JP 2022549760A JP 2022549760 A JP2022549760 A JP 2022549760A JP 2023513955 A JP2023513955 A JP 2023513955A
Authority
JP
Japan
Prior art keywords
sars
cov
seq
composition
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549760A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021168478A5 (fr
Inventor
ケリー リ
イオアンナ パガニ
ピウス ブルゾスカ
ジシェン リ
チュンリン ワン
キャスリーン ハヤシバラ
マイケル タナー
ホン ジ
カミニ ヴァルマ
ファンチ フ
ロバート テブス
Original Assignee
ライフ テクノロジーズ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライフ テクノロジーズ コーポレーション filed Critical ライフ テクノロジーズ コーポレーション
Publication of JP2023513955A publication Critical patent/JP2023513955A/ja
Publication of JPWO2021168478A5 publication Critical patent/JPWO2021168478A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022549760A 2020-02-18 2021-02-18 ウイルス配列を検出するための組成物、キット、及び方法 Pending JP2023513955A (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US202062978274P 2020-02-18 2020-02-18
US62/978,274 2020-02-18
US202062981938P 2020-02-26 2020-02-26
US62/981,938 2020-02-26
US202063044160P 2020-06-25 2020-06-25
US63/044,160 2020-06-25
US202063052385P 2020-07-15 2020-07-15
US63/052,385 2020-07-15
US202062706081P 2020-07-30 2020-07-30
US62/706,081 2020-07-30
US202063198134P 2020-09-30 2020-09-30
US63/198,134 2020-09-30
US202063198421P 2020-10-16 2020-10-16
US63/198,421 2020-10-16
US202063199076P 2020-12-04 2020-12-04
US63/199,076 2020-12-04
US202163199570P 2021-01-08 2021-01-08
US63/199,570 2021-01-08
PCT/US2021/070163 WO2021168478A1 (fr) 2020-02-18 2021-02-18 Compositions, kits et procédés pour la détection de séquences virales

Publications (2)

Publication Number Publication Date
JP2023513955A true JP2023513955A (ja) 2023-04-04
JPWO2021168478A5 JPWO2021168478A5 (fr) 2024-02-26

Family

ID=75540091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549760A Pending JP2023513955A (ja) 2020-02-18 2021-02-18 ウイルス配列を検出するための組成物、キット、及び方法

Country Status (9)

Country Link
US (3) US20210292856A1 (fr)
EP (2) EP3911769B1 (fr)
JP (1) JP2023513955A (fr)
KR (1) KR20220155998A (fr)
CN (1) CN116113714A (fr)
AU (1) AU2021224298A1 (fr)
BR (1) BR112022016493A2 (fr)
CA (1) CA3173545A1 (fr)
WO (1) WO2021168478A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021183893A1 (fr) * 2020-03-13 2021-09-16 The Translational Genomics Research Institute Procédés et kits pour la détection du sras-cov-2
US20220333215A1 (en) * 2020-03-31 2022-10-20 The Hopes Institute Methods and compositions for detecting co-infection with sars-cov-2 and influenza a virus and/or influenza b virus
EP4127166A4 (fr) * 2020-03-31 2024-04-17 Bioskryb Genomics, Inc. Détection de virus à faible abondance
US20210324486A1 (en) * 2020-04-20 2021-10-21 Thomas Jefferson University Method and Primers for the Sensitive and Specific Detection of SARS-CoV-2
EP4192982A2 (fr) * 2020-08-06 2023-06-14 F. Hoffmann-La Roche AG Compositions et procédés pour détecter le coronavirus 2 du syndrome respiratoire aigu sévère (sars-2), de la grippe a et de la grippe b
CN113801963B (zh) * 2021-09-17 2024-03-26 佛山科学技术学院 一种检测冠状病毒的引物探针组合、试剂盒及方法
CN114134143A (zh) * 2021-12-23 2022-03-04 郑州安图生物工程股份有限公司 检测标志物、引物、探针或其组合，以及检测试剂、检测试剂盒
WO2023170297A1 (fr) * 2022-03-10 2023-09-14 Genxpro Gmbh Procédés de détection de variants génomiques du sars-cov-2 dans des dosages multiplex
WO2023230590A2 (fr) * 2022-05-27 2023-11-30 Bowling Green State University Aptamères d'adn en tant qu'inhibiteurs universels d'interactions protéine de spicule/hace2
EP4317459A1 (fr) * 2022-08-04 2024-02-07 National and Kapodistrian University of Athens Procédé de détection de sras-cov-2 par pcr numérique
WO2024102839A1 (fr) * 2022-11-10 2024-05-16 Life Technologies Corporation Compositions, kits et procédés de détection de séquences virales

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079352A (en) 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
US5618711A (en) 1986-08-22 1997-04-08 Hoffmann-La Roche Inc. Recombinant expression vectors and purification methods for Thermus thermophilus DNA polymerase
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US6127155A (en) 1986-08-22 2000-10-03 Roche Molecular Systems, Inc. Stabilized thermostable nucleic acid polymerase compositions containing non-ionic polymeric detergents
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5436134A (en) 1993-04-13 1995-07-25 Molecular Probes, Inc. Cyclic-substituted unsymmetrical cyanine dyes
US5658751A (en) 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
US6821727B1 (en) 1993-11-15 2004-11-23 Applera Corporation Hybridization assay using self-quenching fluorescence probe
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5801155A (en) 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
CA2495051C (fr) 2002-08-05 2012-04-24 Quanta Biosciences Ameliorations apportees a des compositions pour l'amplification in vitro d'acides nucleiques
US8862448B2 (en) 2009-10-19 2014-10-14 Theranos, Inc. Integrated health data capture and analysis system
BR112014000138B1 (pt) 2011-07-06 2021-11-16 Quest Diagnostics Investments Incorporation Método para identificar a presença ou ausência de um ácido nucleico alvo
WO2015085194A1 (fr) 2013-12-06 2015-06-11 The Broad Institute, Inc. Méthodes améliorées d'hybridation de l'acide ribonucléique
WO2017088169A1 (fr) 2015-11-27 2017-06-01 Coyote Bioscience Co., Ltd. Procédés et systèmes d'amplification d'acides nucléiques
CN110468237B (zh) 2016-03-10 2023-06-30 广州达安基因股份有限公司 检测中东呼吸综合征冠状病毒的引物探针混合液及试剂盒
US20190002963A1 (en) 2017-06-28 2019-01-03 ChromaCode, Inc. Multiplexed fluorometric measurements with droplet pcr systems
GB201812428D0 (en) 2018-07-31 2018-09-12 Bg Res Ltd Improved method for pathogen detection
JP2020080806A (ja) 2018-11-30 2020-06-04 株式会社島津製作所 Ｒｎａウイルス検出方法
WO2020242985A1 (fr) 2019-05-24 2020-12-03 Clear Labs, Inc. Procédés et kits pour détecter des pathogènes
CN111088405A (zh) * 2020-02-06 2020-05-01 苏州行知康众生物科技有限公司 用于检测冠状病毒2019-nCoV的引物探针组合物、试剂盒及方法
CN111172239A (zh) 2020-02-28 2020-05-19 上海思路迪医学检验所有限公司 一种病毒样本保存液、核酸提取试剂及病毒核酸提取方法
CN111172327A (zh) 2020-03-05 2020-05-19 杭州丹威生物科技有限公司 一种免提取新型冠状病毒核酸检测的方法与试剂盒
CN111270013A (zh) * 2020-03-12 2020-06-12 宁波海尔施基因科技有限公司 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物
CN111304368A (zh) 2020-03-19 2020-06-19 艾康生物技术(杭州)有限公司 用于检测新型冠状病毒的方法、寡核苷酸和试剂盒
CN111394513B (zh) 2020-03-24 2023-05-12 中国医学科学院病原生物学研究所 新型冠状病毒SARS-CoV-2荧光定量PCR检测方法及其应用
CN111206121A (zh) 2020-03-31 2020-05-29 江苏达伯药业有限公司 一种用于检测新型冠状病毒orflab和S基因的试剂盒
CN111321252B (zh) 2020-04-17 2021-06-15 山东仕达思生物产业有限公司 一种具有抗突变性能的新型冠状病毒核酸检测引物对、试剂盒及其应用
CN111394431B (zh) 2020-05-26 2023-03-21 鲲石生物科技(深圳)有限公司 一种使用双重实时荧光等温扩增技术检测核酸的方法
CN111471803A (zh) 2020-05-29 2020-07-31 武汉生命之美科技有限公司 一种新型冠状病毒covid-19感染检测试剂盒
CN111808988A (zh) 2020-06-09 2020-10-23 广州市金圻睿生物科技有限责任公司 一种covid-19核酸释放剂及核酸检测试剂盒
CN111748649A (zh) 2020-06-13 2020-10-09 上海同进基因科技有限公司 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒
CN111676325A (zh) 2020-07-07 2020-09-18 云南科耀生物科技有限公司 一种用于检测SARS-CoV-2全基因组的引物组合及应用方法
CN111850166A (zh) 2020-07-10 2020-10-30 中国人民解放军总医院第五医学中心 一种大规模筛查新型冠状病毒感染人群的核酸检测方法及应用
CN112126713A (zh) 2020-07-16 2020-12-25 上海之江生物科技股份有限公司 一种冠状病毒和流感病毒联合检测产品及其用途
CN111733290A (zh) 2020-07-16 2020-10-02 北京贝尔生物工程股份有限公司 一种检测新型冠状病毒及近缘冠状病毒的试剂盒及其制备方法
CN112063635B (zh) 2020-07-25 2023-02-17 上海市公共卫生临床中心 一种rna病毒的靶点序列及其应用
CN111808995A (zh) 2020-07-29 2020-10-23 江苏宏微特斯医药科技有限公司 一种呼吸道病原体核酸检测试剂盒
CN111778362A (zh) 2020-08-10 2020-10-16 深圳容金科技有限公司 一种冻干的新型冠状病毒、流感病毒、肺炎病毒核酸检测试剂盒与检测方法

Also Published As

Publication number Publication date
US20210292856A1 (en) 2021-09-23
EP3911769B1 (fr) 2022-11-02
EP4056719A1 (fr) 2022-09-14
US20210292857A1 (en) 2021-09-23
KR20220155998A (ko) 2022-11-24
WO2021168478A1 (fr) 2021-08-26
US11214843B2 (en) 2022-01-04
BR112022016493A2 (pt) 2022-10-25
CN116113714A (zh) 2023-05-12
US20220186328A1 (en) 2022-06-16
CA3173545A1 (fr) 2021-08-26
EP3911769A1 (fr) 2021-11-24
AU2021224298A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
JP2023513955A (ja) ウイルス配列を検出するための組成物、キット、及び方法
Shen et al. Recent advances and perspectives of nucleic acid detection for coronavirus
Huang et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
Kostyusheva et al. CRISPR-Cas systems for diagnosing infectious diseases
CN114058679B (zh) 一种crispr级联核酸检测系统及其检测方法与应用
WO2019192156A1 (fr) Procédé de détection d'acide nucléique sur la base d'une protéine argonaute procaryote et son application
CN116171333A (zh) 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法
US20230175081A1 (en) Means and methods for detecting novel coronavirus (sars-cov-2)
WO2022257002A1 (fr) Réactif de détection de rt-pcr pour la détection de nouveaux coronavirus, kit et procédé de détection associé
US20080090224A1 (en) Nucleic acid detection
EP4192982A2 (fr) Compositions et procédés pour détecter le coronavirus 2 du syndrome respiratoire aigu sévère (sars-2), de la grippe a et de la grippe b
EP4118232A1 (fr) Procédés d'empreinte moléculaire pour détecter et génotyper différentes cibles d'arn par réaction en chaîne de la polymérase à transcription inverse en une seule réaction
WO2022159874A1 (fr) Compositions, kits et méthodes de détection de séquences de variants viraux
KR102435116B1 (ko) CRISPR-Cas 시스템과 멀티플렉스 LAMP 프라이머 세트를 이용한 인플루엔자 바이러스의 검출 방법
EP4355918A1 (fr) Procédés d'amplification à médiation par transcription pour la détection d'arn
Li et al. One-pot, ultrasensitive, and multiplex detection of SARS-CoV-2 genes utilizing self-priming hairpin-mediated isothermal amplification
WO2024102839A1 (fr) Compositions, kits et procédés de détection de séquences virales
US20240124947A1 (en) Compositions for coronavirus detection and methods of making and using therof
US20230094433A1 (en) Methods and kits for the detection of sars-cov-2
WO2022203748A1 (fr) Compositions, kits et procédés de détection de séquences virales cibles résistant à des variants
WO2024148013A1 (fr) Compositions, kits et méthodes pour la détection de séquences virales
WO2024054925A1 (fr) Compositions, kits et méthodes de détection de séquences de variants viraux
WO2022047127A1 (fr) Compositions et méthodes de détection de coronavirus
WO2023014729A1 (fr) Compositions, kits et procédés de détection de charges de séquences d'acides nucléiques
WO2022258658A1 (fr) Procédé et kits pour détecter une infection virale associée au sras dans un échantillon biologique

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240215